Don’t Miss TipRanks’ Half-Year Sale
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Meta Financial Group ( (CASH) ) has provided an update.
On May 22, 2025, Pathward Financial, Inc. received a notice from Nasdaq indicating non-compliance with the Nasdaq Listing Rule 5250(c)(1) due to the late filing of its Quarterly Report for the fiscal quarter ended March 31, 2025. The company has 60 days to submit a compliance plan and potentially up to 180 days to regain compliance. This notice does not immediately affect the trading of the company’s stock, and Pathward Financial intends to address the issue promptly.
The most recent analyst rating on (CASH) stock is a Buy with a $75.00 price target. To see the full list of analyst forecasts on Meta Financial Group stock, see the CASH Stock Forecast page.
Spark’s Take on CASH Stock
According to Spark, TipRanks’ AI Analyst, CASH is a Outperform.
Meta Financial Group’s stock is rated at 75, reflecting strong financial performance and a positive earnings outlook. The company’s solid financial health and strategic growth initiatives support its potential for future growth. However, technical indicators suggest caution, and the low dividend yield might not appeal to income-focused investors.
To see Spark’s full report on CASH stock, click here.
More about Meta Financial Group
Pathward Financial, Inc. is a U.S.-based financial holding company focused on enhancing financial inclusion. Through its subsidiary, Pathward®, N.A., the company aims to increase financial availability, choice, and opportunity across its Partner Solutions and Commercial Finance business lines, supporting both individuals and businesses.
Average Trading Volume: 217,105
Technical Sentiment Signal: Buy
Current Market Cap: $1.87B
For an in-depth examination of CASH stock, go to TipRanks’ Stock Analysis page.